Sign In
Buy MRKR
$1.45
+0.0300 (+2.11%)
At Close: Jun 03, 2026
Fly Intel: Pre-market Movers ATHX;MRKR;MUR;BCRX;BA;TXN;ACB;NXPI;CAT
01:11pm, Monday, 13'th Apr 2020
Fly Intel: Pre-market Movers ATHX MRKR MUR BCRX BA TXN ACB NXPI CAT
20 Healthcare Stocks Moving In Monday's Pre-Market Session
11:39am, Monday, 13'th Apr 2020
Gainers
• Biocept, Inc. (NASDAQ:BIOC) stock moved upwards by 55.72% to $0.56 during Monday's pre-market session.
• BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock...
Coronavirus update: 1.72 million cases worldwide, 106,469 deaths; U.S. surpasses Italy in number of fatalities
05:59pm, Saturday, 11'th Apr 2020
The number of U.S. cases of the coronavirus that causes COVID-19 rose above 500,000 on Friday, while the death toll climbed by more than 2,000 to surpass...
FDA grants emergency authorization to two blood purification systems
10:24pm, Friday, 10'th Apr 2020
The Food and Drug Administration (FDA) on Friday issued emergency use authorizations to blood purification devices manufactured by Terumo Corp. undefined and...
FDA grants emergency authorization to two blood purification systems
10:24pm, Friday, 10'th Apr 2020
The Food and Drug Administration (FDA) on Friday issued emergency use authorizations to blood purification devices manufactured by Terumo Corp. and Marker Therapeutics AG in response to the COVID-19
Head of Kensington primary vows 'we will stay open' but has contingency plans
12:46pm, Wednesday, 18'th Mar 2020
Jagdeep Birdi at Colville Primary School in Portobello is abiding by government guidance
Schools in England struggle to stay open as coronavirus hits attendance
03:39pm, Tuesday, 17'th Mar 2020
Headteachers question official policy of staying open as staff and students stay at home
Coronavirus UK - Teachers demand explanation from Johnson on decision not to shut schools
06:26pm, Sunday, 15'th Mar 2020
The London Economic | Coronavirus UK - Teachers demand explanation from Johnson on decision not to shut schools | News
Marker Therapeutics Reports Full Year 2019 Operating and Financial Results
08:01pm, Thursday, 12'th Mar 2020
Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological ma
Marker Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 million
12:00pm, Monday, 02'nd Mar 2020
Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological mal
Teachers criticise new assessments for four-year-olds
02:26pm, Wednesday, 26'th Feb 2020
The London Economic | The new Reception Baseline Assessment will be rolled out across all primary schools from September.| News
Marker Therapeutics to Present at Two Upcoming Investor Conferences
12:00pm, Tuesday, 18'th Feb 2020
Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological mal
S, TMUS among premarket gainers
02:18pm, Tuesday, 11'th Feb 2020
Sprint (NYSE:S) +74% after judge approves T-Mobile merger.Rexahn Pharmaceuticals (NASDAQ:REXN) +25%.ZK International Group (NASDAQ:ZKIN) +21% on supplying stainless steel pipe and fitting products f
Marker Therapeutics Announces Update to its Clinical Program in AML
12:00pm, Tuesday, 11'th Feb 2020
Marker Therapeutics, Inc. (NASDAQ: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological ma
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
12:51pm, Tuesday, 04'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Bioscie
